✦ LIBER ✦

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999

✍ Scribed by Cripe, L. D.; Uno, H.; Paietta, E. M.; Litzow, M. R.; Ketterling, R. P.; Bennett, J. M.; Rowe, J. M.; Lazarus, H. M.; Luger, S.; Tallman, M. S.

Book ID: 118740242
Publisher: American Society of Hematology
Year: 2010
Tongue: English
Weight: 485 KB
Volume: 116
Category: Article
ISSN: 0006-4971
DOI: 10.1182/blood-2010-04-277269

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Failure of three novel regimens to impro

Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group

✍ Mark R. Litzow; Megan Othus; Larry D. Cripe; Steven D. Gore; Hillard M. Lazarus; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

A phase I study of induction chemotherap

A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617

✍ Thomas R Chauncey; Cathryn Rankin; Jeanne E Anderson; I-Ming Chen; Kenneth J Kop 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Sequential Combination of Gemtuzumab Ozo

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

✍ Amadori, S.; Suciu, S.; Stasi, R.; Salih, H. R.; Selleslag, D.; Muus, P.; De Fab 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 249 KB